| # | Pathway | Proteins |
|---|
| 1 | Malaria | ENSAPLP00000016307, ENSAPLP00000015337, ENSAPLP00000007488, ENSAPLP00000005443 |
| 2 | African trypanosomiasis | ENSAPLP00000003774, ENSAPLP00000016307, ENSAPLP00000007488, ENSAPLP00000005443 |
| 3 | Salmonella infection | ENSAPLP00000009727, ENSAPLP00000014040, ENSAPLP00000003050, ENSAPLP00000015489, ENSAPLP00000009311, ENSAPLP00000006991 |
| 4 | Vitamin digestion and absorption | ENSAPLP00000011529, ENSAPLP00000003561, ENSAPLP00000016339 |
| 5 | Dilated cardiomyopathy | ENSAPLP00000003774, ENSAPLP00000012522, ENSAPLP00000003657, ENSAPLP00000012136, ENSAPLP00000003219, ENSAPLP00000003991 |
| 6 | Fat digestion and absorption | ENSAPLP00000011529, ENSAPLP00000003561, ENSAPLP00000016339 |
| 7 | Amoebiasis | ENSAPLP00000003774, ENSAPLP00000012216, ENSAPLP00000008118, ENSAPLP00000007907, ENSAPLP00000012559, ENSAPLP00000004050 |
| 8 | Primary bile acid biosynthesis | ENSAPLP00000002356, ENSAPLP00000009740 |
| 9 | Synaptic vesicle cycle | ENSAPLP00000006097, ENSAPLP00000011991, ENSAPLP00000006303, ENSAPLP00000000706 |
| 10 | Cardiac muscle contraction | ENSAPLP00000003657, ENSAPLP00000012136, ENSAPLP00000003219, ENSAPLP00000003991 |
| 11 | Vascular smooth muscle contraction | ENSAPLP00000005411, ENSAPLP00000015489, ENSAPLP00000006991, ENSAPLP00000002381, ENSAPLP00000013090 |
| 12 | Protein digestion and absorption | ENSAPLP00000008118, ENSAPLP00000008210, ENSAPLP00000012993, ENSAPLP00000000439 |
| 13 | Hypertrophic cardiomyopathy (HCM) | ENSAPLP00000012522, ENSAPLP00000003657, ENSAPLP00000012136, ENSAPLP00000003219, ENSAPLP00000003991 |
| 14 | cGMP-PKG signaling pathway | ENSAPLP00000012100, ENSAPLP00000005411, ENSAPLP00000009427, ENSAPLP00000009642, ENSAPLP00000013090 |
| 15 | Adrenergic signaling in cardiomyocytes | ENSAPLP00000003657, ENSAPLP00000012136, ENSAPLP00000003219, ENSAPLP00000003991, ENSAPLP00000009642 |
| 16 | Legionellosis | ENSAPLP00000009308, ENSAPLP00000010584, ENSAPLP00000004026 |
| 17 | Collecting duct acid secretion | ENSAPLP00000006097, ENSAPLP00000002717 |
| 18 | Endocrine and other factor-regulated calcium reabsorption | ENSAPLP00000011991, ENSAPLP00000006303, ENSAPLP00000000706 |
| 19 | Bacterial invasion of epithelial cells | ENSAPLP00000011991, ENSAPLP00000003050, ENSAPLP00000000706, ENSAPLP00000012559, ENSAPLP00000015963 |
| 20 | Regulation of lipolysis in adipocytes | ENSAPLP00000005715, ENSAPLP00000009642 |
| 21 | Proteoglycans in cancer | ENSAPLP00000005854, ENSAPLP00000013972, ENSAPLP00000003050, ENSAPLP00000009311, ENSAPLP00000012559, ENSAPLP00000013831, ENSAPLP00000013792 |
| 22 | Phototransduction | ENSAPLP00000010816 |
| 23 | Butirosin and neomycin biosynthesis | ENSAPLP00000009741 |
| 24 | Gastric acid secretion | ENSAPLP00000005411, ENSAPLP00000002717, ENSAPLP00000009642 |
| 25 | Tight junction | ENSAPLP00000015489, ENSAPLP00000012466, ENSAPLP00000006991, ENSAPLP00000009642, ENSAPLP00000013090 |
| 26 | Calcium signaling pathway | ENSAPLP00000003774, ENSAPLP00000012100, ENSAPLP00000005411, ENSAPLP00000009427 |
| 27 | Regulation of actin cytoskeleton | ENSAPLP00000009727, ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000015489, ENSAPLP00000012559, ENSAPLP00000006991, ENSAPLP00000013090 |
| 28 | Phagosome | ENSAPLP00000003774, ENSAPLP00000006097, ENSAPLP00000014040, ENSAPLP00000003050, ENSAPLP00000015503 |
| 29 | Renin secretion | ENSAPLP00000015747, ENSAPLP00000009642 |
| 30 | Focal adhesion | ENSAPLP00000008118, ENSAPLP00000003050, ENSAPLP00000005411, ENSAPLP00000009311, ENSAPLP00000012559, ENSAPLP00000000439, ENSAPLP00000013090 |
| 31 | Asthma | ENSAPLP00000003774 |
| 32 | Pathways in cancer | ENSAPLP00000008118, ENSAPLP00000010816, ENSAPLP00000005537, ENSAPLP00000012628, ENSAPLP00000013972, ENSAPLP00000003050, ENSAPLP00000012559, ENSAPLP00000009642 |
| 33 | Huntington's disease | ENSAPLP00000012100, ENSAPLP00000011991, ENSAPLP00000006303, ENSAPLP00000009427, ENSAPLP00000000706, ENSAPLP00000001822 |
| 34 | Starch and sucrose metabolism | ENSAPLP00000009916, ENSAPLP00000009741 |
| 35 | Morphine addiction | ENSAPLP00000010816, ENSAPLP00000009642 |
| 36 | VEGF signaling pathway | ENSAPLP00000003050, ENSAPLP00000004050 |
| 37 | Rheumatoid arthritis | ENSAPLP00000003774, ENSAPLP00000006097 |
| 38 | Leukocyte transendothelial migration | ENSAPLP00000013972, ENSAPLP00000003050, ENSAPLP00000009642, ENSAPLP00000013090 |
| 39 | GABAergic synapse | ENSAPLP00000010816, ENSAPLP00000009642 |
| 40 | Amyotrophic lateral sclerosis (ALS) | ENSAPLP00000003050, ENSAPLP00000001822 |
| 41 | Nitrogen metabolism | ENSAPLP00000002717 |
| 42 | Taste transduction (no map in kegg database) | ENSAPLP00000010816 |
| 43 | B cell receptor signaling pathway | ENSAPLP00000003774, ENSAPLP00000003050 |
| 44 | Pancreatic secretion | ENSAPLP00000003050, ENSAPLP00000002717 |
| 45 | cAMP signaling pathway | ENSAPLP00000003050, ENSAPLP00000009642, ENSAPLP00000013090 |
| 46 | PI3K-Akt signaling pathway | ENSAPLP00000003774, ENSAPLP00000008118, ENSAPLP00000010816, ENSAPLP00000003050, ENSAPLP00000012559, ENSAPLP00000000439 |
| 47 | Amino sugar and nucleotide sugar metabolism | ENSAPLP00000009916, ENSAPLP00000009741 |
| 48 | Allograft rejection | ENSAPLP00000003774 |
| 49 | Transcriptional misregulation in cancer | ENSAPLP00000003774, ENSAPLP00000013972 |
| 50 | Retrograde endocannabinoid signaling | ENSAPLP00000010816, ENSAPLP00000009642 |
| 51 | Axon guidance | ENSAPLP00000009975, ENSAPLP00000003050, ENSAPLP00000009642 |
| 52 | Natural killer cell mediated cytotoxicity | ENSAPLP00000003774, ENSAPLP00000003050 |
| 53 | Glutathione metabolism | ENSAPLP00000005537, ENSAPLP00000001822 |
| 54 | Fc epsilon RI signaling pathway | ENSAPLP00000003774, ENSAPLP00000003050 |
| 55 | Vibrio cholerae infection | ENSAPLP00000006097, ENSAPLP00000004026 |
| 56 | Glutamatergic synapse | ENSAPLP00000010816, ENSAPLP00000009642 |
| 57 | Alcoholism | ENSAPLP00000010816, ENSAPLP00000001720, ENSAPLP00000009642 |
| 58 | Carbohydrate digestion and absorption | ENSAPLP00000009741 |
| 59 | Intestinal immune network for IgA production | ENSAPLP00000003774 |
| 60 | Phenylalanine metabolism | ENSAPLP00000005038 |
| 61 | Proximal tubule bicarbonate reclamation | ENSAPLP00000002717 |
| 62 | Viral myocarditis | ENSAPLP00000003774, ENSAPLP00000003050 |
| 63 | ECM-receptor interaction | ENSAPLP00000008118, ENSAPLP00000012559, ENSAPLP00000000439 |
| 64 | PPAR signaling pathway | ENSAPLP00000005715, ENSAPLP00000006229 |
| 65 | Primary immunodeficiency | ENSAPLP00000003774 |
| 66 | Dorso-ventral axis formation | ENSAPLP00000016323 |
| 67 | Autoimmune thyroid disease | ENSAPLP00000003774 |
| 68 | Type II diabetes mellitus | ENSAPLP00000009741 |
| 69 | Circadian entrainment | ENSAPLP00000010816, ENSAPLP00000009642 |
| 70 | Cholinergic synapse | ENSAPLP00000010816, ENSAPLP00000009642 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection | ENSAPLP00000006097, ENSAPLP00000003050 |
| 72 | Oxytocin signaling pathway | ENSAPLP00000005411, ENSAPLP00000009642, ENSAPLP00000013090 |
| 73 | Cocaine addiction | ENSAPLP00000009642 |
| 74 | Thyroid cancer | ENSAPLP00000012628 |
| 75 | Renin-angiotensin system | ENSAPLP00000015747 |
| 76 | Serotonergic synapse | ENSAPLP00000010816, ENSAPLP00000009642 |
| 77 | Chemokine signaling pathway | ENSAPLP00000010816, ENSAPLP00000003050, ENSAPLP00000009642 |
| 78 | Bile secretion | ENSAPLP00000002717 |
| 79 | p53 signaling pathway | ENSAPLP00000003567 |
| 80 | Bladder cancer | ENSAPLP00000013972 |
| 81 | Notch signaling pathway | ENSAPLP00000016323 |
| 82 | Peroxisome | ENSAPLP00000009740, ENSAPLP00000006873 |
| 83 | Small cell lung cancer | ENSAPLP00000008118, ENSAPLP00000012559 |
| 84 | MicroRNAs in cancer | ENSAPLP00000016323, ENSAPLP00000013972, ENSAPLP00000003219 |
| 85 | Porphyrin and chlorophyll metabolism | ENSAPLP00000007495 |
| 86 | Olfactory transduction | ENSAPLP00000010816 |
| 87 | Gap junction | ENSAPLP00000015503, ENSAPLP00000009642 |
| 88 | Sphingolipid signaling pathway | ENSAPLP00000003050, ENSAPLP00000009642 |
| 89 | Phospholipase D signaling pathway | ENSAPLP00000003774, ENSAPLP00000004026 |
| 90 | Shigellosis | ENSAPLP00000009727, ENSAPLP00000003050 |
| 91 | Mineral absorption | ENSAPLP00000015679 |
| 92 | N-Glycan biosynthesis | ENSAPLP00000006600 |
| 93 | Metabolism of xenobiotics by cytochrome P450 | ENSAPLP00000005537 |
| 94 | Drug metabolism - cytochrome P450 | ENSAPLP00000005537 |
| 95 | Estrogen signaling pathway | ENSAPLP00000013972, ENSAPLP00000009642 |
| 96 | Hematopoietic cell lineage | ENSAPLP00000003774 |
| 97 | Systemic lupus erythematosus | ENSAPLP00000003774, ENSAPLP00000001720 |
| 98 | Glycolysis / Gluconeogenesis | ENSAPLP00000009916, ENSAPLP00000009741 |
| 99 | Endocytosis | ENSAPLP00000011991, ENSAPLP00000005705, ENSAPLP00000006303, ENSAPLP00000000706, ENSAPLP00000008988, ENSAPLP00000004026 |
| 100 | Fc gamma R-mediated phagocytosis | ENSAPLP00000003774, ENSAPLP00000003050 |
| 101 | Complement and coagulation cascades | ENSAPLP00000010484, ENSAPLP00000006069 |
| 102 | Galactose metabolism | ENSAPLP00000009741 |
| 103 | Tyrosine metabolism | ENSAPLP00000005038 |
| 104 | Arachidonic acid metabolism | ENSAPLP00000001822 |
| 105 | Fructose and mannose metabolism | ENSAPLP00000009741 |
| 106 | TGF-beta signaling pathway | ENSAPLP00000013831 |
| 107 | MAPK signaling pathway | ENSAPLP00000003050, ENSAPLP00000009311, ENSAPLP00000004050 |
| 108 | Rap1 signaling pathway | ENSAPLP00000009727, ENSAPLP00000003050, ENSAPLP00000009642 |
| 109 | HIF-1 signaling pathway | ENSAPLP00000015679, ENSAPLP00000009741 |
| 110 | Chemical carcinogenesis | ENSAPLP00000005537 |
| 111 | Leishmaniasis | ENSAPLP00000003774 |
| 112 | Colorectal cancer | ENSAPLP00000003050 |
| 113 | Steroid hormone biosynthesis | ENSAPLP00000002356 |
| 114 | Influenza A (no map in kegg database) | ENSAPLP00000012100, ENSAPLP00000009427 |
| 115 | Lysosome | ENSAPLP00000011991, ENSAPLP00000009330, ENSAPLP00000000706 |
| 116 | NF-kappa B signaling pathway | ENSAPLP00000003774 |
| 117 | Pancreatic cancer | ENSAPLP00000003050 |
| 118 | Staphylococcus aureus infection | ENSAPLP00000003774 |
| 119 | Dopaminergic synapse | ENSAPLP00000010816, ENSAPLP00000009642 |
| 120 | Parkinson's disease | ENSAPLP00000012100, ENSAPLP00000009427, ENSAPLP00000009642 |
| 121 | Toll-like receptor signaling pathway | ENSAPLP00000003050 |
| 122 | Progesterone-mediated oocyte maturation | ENSAPLP00000009642 |
| 123 | Vasopressin-regulated water reabsorption | ENSAPLP00000014040 |
| 124 | Pertussis | ENSAPLP00000009642 |
| 125 | Ras signaling pathway | ENSAPLP00000010816, ENSAPLP00000003050 |
| 126 | Central carbon metabolism in cancer | ENSAPLP00000009741 |
| 127 | Thyroid hormone synthesis | ENSAPLP00000001822 |
| 128 | TNF signaling pathway | ENSAPLP00000013972 |
| 129 | Pentose phosphate pathway | ENSAPLP00000009916 |
| 130 | Choline metabolism in cancer | ENSAPLP00000003050 |
| 131 | Epstein-Barr virus infection | ENSAPLP00000003774, ENSAPLP00000004938, ENSAPLP00000004050 |
| 132 | Renal cell carcinoma | ENSAPLP00000003050 |
| 133 | Prostate cancer (no map in kegg database) | ENSAPLP00000005537 |
| 134 | Salivary secretion | ENSAPLP00000009817 |
| 135 | Long-term depression | ENSAPLP00000009642 |
| 136 | Melanogenesis | ENSAPLP00000009642 |
| 137 | Measles | ENSAPLP00000003774 |
| 138 | Prion diseases (no map in kegg database) | ENSAPLP00000016323 |
| 139 | HTLV-I infection | ENSAPLP00000012100, ENSAPLP00000009427 |
| 140 | Platelet activation | ENSAPLP00000005411, ENSAPLP00000009642 |
| 141 | Osteoclast differentiation | ENSAPLP00000003050 |
| 142 | Chagas disease (American trypanosomiasis) | ENSAPLP00000009642 |
| 143 | RNA degradation | ENSAPLP00000006939 |
| 144 | Proteasome | ENSAPLP00000004938 |
| 145 | AMPK signaling pathway | ENSAPLP00000005193 |
| 146 | Thyroid hormone signaling pathway | ENSAPLP00000016323 |
| 147 | Wnt signaling pathway | ENSAPLP00000003050 |
| 148 | Viral carcinogenesis | ENSAPLP00000003050, ENSAPLP00000001720 |
| 149 | Hepatitis B | ENSAPLP00000013972 |
| 150 | Toxoplasmosis | ENSAPLP00000009642 |
| 151 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | ENSAPLP00000012522 |
| 152 | Adherens junction | ENSAPLP00000003050 |
| 153 | Neurotrophin signaling pathway | ENSAPLP00000003050 |
| 154 | Pathogenic Escherichia coli infection | ENSAPLP00000015503 |
| 155 | Tuberculosis | ENSAPLP00000003774 |
| 156 | Ribosome | ENSAPLP00000011353, ENSAPLP00000008818 |
| 157 | Spliceosome | ENSAPLP00000005529, ENSAPLP00000004567 |
| 158 | RNA transport | ENSAPLP00000006298, ENSAPLP00000012628 |
| 159 | Insulin signaling pathway | ENSAPLP00000009741 |
| 160 | Non-alcoholic fatty liver disease (NAFLD) | ENSAPLP00000003050 |
| 161 | Carbon metabolism (no map in kegg database) | ENSAPLP00000009916, ENSAPLP00000009741 |
| 162 | Oxidative phosphorylation | ENSAPLP00000006097 |
| 163 | Alzheimer's disease | ENSAPLP00000015337 |
| 164 | Protein processing in endoplasmic reticulum | ENSAPLP00000006600 |
| 165 | Metabolic pathways (no map in kegg database) | ENSAPLP00000006097, ENSAPLP00000009916, ENSAPLP00000006600, ENSAPLP00000002356, ENSAPLP00000009740, ENSAPLP00000009741 |